Literature DB >> 22836914

Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.

Martin C S Wong1, George K John, Hoyee W Hirai, Thomas Y T Lam, Arthur K C Luk, Jessica Y L Ching, Simon S M Ng, Francis K L Chan, Sian M Griffiths, Joseph J Y Sung.   

Abstract

PURPOSE: Colorectal cancer (CRC) is one of the leading causes of cancer mortality worldwide. This study examined factors influencing the choice of participants between colonoscopy and fecal immunochemical test (FIT) in a screening program and the impact of an unbiased educational session on influencing this decision.
METHODS: Data from 7,845 participants who underwent screening between May 2008 and April 2011 was analyzed. Binary logistic regression and multinomial regression were performed to calculate the odds of selection of colonoscopy instead of FIT and the impact of the educational session on final participant choice, respectively.
RESULTS: Of the 7,845 participants, 4,796 (61 %) underwent FIT and 3,049 (39 %) underwent colonoscopy. A significant number of participants changed their initial choice after the educational session, with 27.1 % changing to FIT from colonoscopy and 8 % changing from FIT to colonoscopy. Age, educational level, occupation, income, family history of CRC, perception of risk of CRC, and perceptions regarding CRC screening were significantly different among the groups choosing FIT and colonoscopy. Family history of CRC and high self-perception of CRC risk resulted in higher odds of choosing colonoscopy, whereas older age, single marital status, and negative perception of CRC screening resulted in lower odds. Perceptions of overall health status, occupation, low income, younger age, and negative perceptions of CRC screening were associated with higher odds of change in screening choice.
CONCLUSIONS: Those at higher odds of changing CRC screening options should be supported with more detailed explanations by primary care physicians to secure a more informed and considered choice.

Entities:  

Mesh:

Year:  2012        PMID: 22836914     DOI: 10.1007/s10552-012-0031-x

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  13 in total

1.  Regret on choice of colorectal cancer screening modality was associated with poorer screening compliance: a 4-year prospective cohort study.

Authors:  Martin C S Wong; Jessica Y L Ching; Victor C W Chan; Renee Bruggemann; Thomas Y T Lam; Arthur K C Luk; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

2.  Should prior FIT results be incorporated as an additional variable to estimate risk of colorectal neoplasia? A prospective study of 5,813 screening colonoscopies.

Authors:  Martin C S Wong; Jessica Y L Ching; Victor C W Chan; Jeffrey P Shum; Thomas Y T Lam; Arthur K C Luk; Joseph J Y Sung
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

3.  Validation of a risk prediction score for proximal neoplasia in colorectal cancer screening: a prospective colonoscopy study.

Authors:  Martin C S Wong; Jessica Y L Ching; Victor C W Chan; Raymond S Y Tang; Arthur K C Luk; Thomas Y T Lam; Sunny S H Wong; Siew C Ng; Simon S M Ng; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

4.  Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea.

Authors:  Young-Hak Cho; Dae Ho Kim; Jae Myung Cha; Yoon Tae Jeen; Jeong Seop Moon; Jin-Oh Kim; Sang Kil Lee; Yu Kyung Cho; Jong Pil Im; Jae Young Jang; Jeong Eun Shin; Soon Man Yoon; Yunho Jung; Eun Sun Kim; Kang Nyeong Lee; Soo-Jeong Cho; Yeol Kim; Bo Young Park
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

Review 5.  Quality is the key for emerging issues of population-based colonoscopy screening.

Authors:  Jin Young Yoon; Jae Myung Cha; Yoon Tae Jeen
Journal:  Intest Res       Date:  2018-01-18

6.  Elevated phospholipase A2 activities in plasma samples from multiple cancers.

Authors:  Hui Cai; Elena G Chiorean; Michael V Chiorean; Douglas K Rex; Bruce W Robb; Noah M Hahn; Ziyue Liu; Patrick J Loehrer; Marietta L Harrison; Yan Xu
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

7.  The knowledge of colorectal cancer symptoms and risk factors among 10,078 screening participants: are high risk individuals more knowledgeable?

Authors:  Martin C S Wong; Hoyee W Hirai; Arthur K C Luk; Thomas Y T Lam; Jessica Y L Ching; Sian M Griffiths; Francis K L Chan; Joseph J Y Sung
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

8.  The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy.

Authors:  Martin C S Wong; Jessica Y L Ching; Victor C W Chan; Joseph J Y Sung
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

9.  Perceived obstacles of colorectal cancer screening and their associated factors among 10,078 Chinese participants.

Authors:  Martin C S Wong; Jessica Y L Ching; Hoyee H Hirai; Thomas Y T Lam; Sian M Griffiths; Francis K L Chan; Joseph J Y Sung
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  Determinants of Bowel Preparation Quality and Its Association With Adenoma Detection: A Prospective Colonoscopy Study.

Authors:  Martin C S Wong; Jessica Y L Ching; Victor C W Chan; Thomas Y T Lam; Arthur K C Luk; Raymond S Y Tang; Sunny H Wong; Siew C Ng; Simon S M Ng; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.